Intracellular Catalyst Protocol

Intracellular Catalyst Protocol

B4 COVID-19

A 12-week nicotinamide adenine dinucleotide kit built around a once-weekly routine, clear ingredient detail, and a direct path into secure checkout.

Ingredient

Nicotinamide adenine dinucleotide

Cadence

Once per week

Storage note

2°C to 8°C

12-week kitOnce-weekly routineAdults 18+Support visible

Product overview

One product. One clear path into checkout.

12-week kit
B4 COVID-19 packaging with multi-dose delivery system and micro-interface tips

Kit

B4C19 / 12W

Storage

2°C to 8°C

Format

1x preloaded multi-dose pen

Route

Secure hosted checkout

Protocol

Intracellular Catalyst Protocol

Pack

1 pen / 12 administrations

Boundary note

No therapeutic claims

Single-formulation focus

The storefront stays focused on one 12-week kit, so the buyer sees one formulation, one route into secure checkout, and one clear product story instead of a noisy catalogue.

Ingredient file stays visible

Nicotinamide adenine dinucleotide is written in full where the ingredient story matters, while the public-facing brand world stays sharp and easy to follow.

Storage and boundary notes stay visible

Support, FAQ, disclaimer, shipping, returns, privacy, and terms stay close to the buy path so the presentation feels disciplined and clinical in tone without pretending to be medical advice.

The Science

Ingredient background, gathered in one place.

Explain nicotinamide adenine dinucleotide as an in-cell coenzyme and frame cellular energy, mitochondrial function, and maintenance pathways as reference context rather than promised outcomes.

Explore the science

The B4-Pen

The 12-week pen format, clearly explained.

Show the preloaded pen, the twelve disposable needle tops, refrigerated storage, and the handling story without drifting into pseudo-clinical administration promises.

See the pen

Timeline

The 12-week journey, step by step.

Walk the customer through setup, weekly routine, kit completion, and optional repeat ordering without inventing symptom timelines or biological repair milestones.

View the timeline

Specification sheet

One 12-week kit. One specification sheet. One hosted checkout path.

The storefront stays deliberately narrow so the buyer can understand the product format, ingredient detail, storage guidance, support route, and checkout path without friction.

B4 COVID-19 leads the screen while nicotinamide adenine dinucleotide stays fully spelled out in the ingredient story.
The storefront stays tighter and easier to follow than a generic supplement listing, with clearer format language and visible handling notes.
The public narrative leans into cellular energy, mitochondrial function, maintenance pathways, vitality, and routine consistency without drifting into disease-treatment language.
The kit is presented as a once-weekly 12-week format with one preloaded pen, twelve administrations, twelve disposable needle tops, and refrigerated storage guidance.
This site does not present the product as a COVID-19, post-viral, vaccine-related, or other disease-treatment offer.

FAQ

Questions answered before the buyer has to ask.

The path into checkout should feel informed, calm, and low-friction while keeping the ingredient and product boundary explicit.

B4 COVID-19 is the lead product identity on the site. The storefront is intentionally built around one flagship 12-week kit so the offer is faster to understand and easier to trust.

Final call to action

Review the science, the pen, the timeline, and the checkout path.

The route is intentionally simple: understand the product, confirm the pack details, use support when needed, and move into hosted checkout only when the format fits.